- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 16th, 2007
The Wall Street Transcript has published an in-depth interview with Stephen M. Simes, president and CEO of BioSante Pharmaceuticals, Inc. (AMEX:BPA) in which he talks at length about the Company.
The entire 2,500 word interview is available free online at http://www.twst.com/ceos.htm.
BioSante is developing a pipeline of hormone therapy products to treat both men and women. BioSante's hormone therapy products are gel formulations for transdermal administration that deliver bioidentical estradiol and testosterone. The company also is developing its calcium phosphate nanotechnology (CaP) for novel vaccines, including avian flu and biodefense vaccines for toxins such as anthrax, and drug delivery systems.
|Related News Press|
Nanoscale Trojan horses treat inflammation May 24th, 2016
Programmable materials find strength in molecular repetition May 23rd, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Revealing the nature of magnetic interactions in manganese oxide: New technique for probing local magnetic interactions confirms 'superexchange' model that explains how the material gets its long-range magnetic order May 25th, 2016
Gigantic ultrafast spin currents: Scientists from TU Wien (Vienna) are proposing a new method for creating extremely strong spin currents. They are essential for spintronics, a technology that could replace today's electronics May 25th, 2016
Nanoporous material's strange "breathing" behavior April 7th, 2016
Detecting and identifying explosives with single test December 10th, 2015
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016
UCLA nanoscientists engage shoppers in fun conversations March 8th, 2016
Risk Analysis Publishes Non-Animal Strategy to Assess Nanomaterials February 24th, 2016